Loring Wolcott & Coolidge Fiduciary Advisors’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-900
Closed -$36.6K 567
2023
Q3
$36.6K Hold
900
﹤0.01% 443
2023
Q2
$36.7K Sell
900
-200
-18% -$8.27K ﹤0.01% 455
2023
Q1
$46.1K Buy
+1,100
New +$45.9K ﹤0.01% 417
2022
Q1
Sell
-181
Closed -$7K 661
2021
Q4
$7K Sell
181
-154
-46% -$5.8K ﹤0.01% 638
2021
Q3
$12K Sell
335
-42
-11% -$1.44K ﹤0.01% 567
2021
Q2
$12K Buy
+377
New +$12.1K ﹤0.01% 600
2021
Q1
Sell
-42
Closed -$1K 442
2020
Q4
$1K Buy
+42
New +$1.24K ﹤0.01% 758
2018
Q2
Sell
-140
Closed -$4K 685
2018
Q1
$4K Sell
140
-25
-15% -$675 ﹤0.01% 634
2017
Q4
$5K Hold
165
﹤0.01% 606
2017
Q3
$4K Buy
165
+25
+18% +$669 ﹤0.01% 602
2017
Q2
$4K Buy
+140
New +$3.56K ﹤0.01% 591
2015
Q1
Sell
-140
Closed -$4K 624
2014
Q4
$4K Buy
+140
New +$3.59K ﹤0.01% 601

Other funds holding EXC

Loring Wolcott & Coolidge Fiduciary Advisors's EXC Position: Q4 2023 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Exelon (EXC) in Q4 2023, closing a stake of 900 shares — an estimated $36.6K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in EXC in Q4 2014 and held it in 12 quarters. The position peaked at $46.1K in Q1 2023. 1,018 funds tracked by Wall St. Rank hold EXC as of Q4 2023.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Exelon position as of Q4 2023 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 900 Exelon shares in Q4 2023, an estimated $36.6K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Exelon in Q4 2014 and held it in 12 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Exelon position peaked at $46.1K in Q1 2023.
  • 1,018 funds tracked by Wall St. Rank held Exelon as of Q4 2023.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.